GLOBAL ACCESS DIAGNOSTICS LTD

Global Access Diagnostics (GADx) is a leading end-to-end developer of rapid immuno-diagnostics for human, veterinary and agricultural applications. Founded in 2003 by one of the creators of the Clearblue pregnancy test, GADx offers a comprehensive range of lateral flow immunoassay development services as a contract research organization. GADx has labs and a high volume manufacturing facility in Bedfordshire, UK, as well as labs in Maine, USA. GADx collaborates with a global network to deliver high performance, robust innovations. GADx was formed when Global Access Health acquired two companies, Mologic Ltd. and Global Access Diagnostics Ltd. As part of this transition, GADx became a social enterprise, dedicating its profits and mission to improving the health and wellbeing of underserved populations around the world.